Ocular Therapeutix (OCUL)

Ocular Therapeutix (OCUL) Stock Price & Analysis


OCUL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.57 - $7.32
Previous Close$6.92
Average Volume (3M)978.90K
Market Cap
Enterprise Value$522.06M
Total Cash (Recent Filing)$79.03M
Total Debt (Recent Filing)$64.61M
Price to Earnings (P/E)-6.0
Aug 07, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.16
Shares Outstanding77,524,666
10 Day Avg. Volume1,084,340
30 Day Avg. Volume978,905
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)105.32
Price to Sales (P/S)40.11
Price to Cash Flow (P/CF)-6.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.10
Enterprise Value/Gross Profit11.12
Enterprise Value/Ebitda-6.58
Price Target Upside85.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Ocular Therapeutix’s price range in the past 12 months?
Ocular Therapeutix lowest stock price was $2.57 and its highest was $7.32 in the past 12 months.
    What is Ocular Therapeutix’s market cap?
    Currently, no data Available
    When is Ocular Therapeutix’s upcoming earnings report date?
    Ocular Therapeutix’s upcoming earnings report date is Aug 07, 2023 which is in 63 days.
      How were Ocular Therapeutix’s earnings last quarter?
      Ocular Therapeutix released its earnings results on May 08, 2023. The company reported -$0.39 earnings per share for the quarter, missing the consensus estimate of -$0.263 by -$0.127.
        Is Ocular Therapeutix overvalued?
        According to Wall Street analysts Ocular Therapeutix’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Ocular Therapeutix pay dividends?
          Ocular Therapeutix does not currently pay dividends.
          What is Ocular Therapeutix’s EPS estimate?
          Ocular Therapeutix’s EPS estimate is -$0.28.
            How many shares outstanding does Ocular Therapeutix have?
            Ocular Therapeutix has 77,524,666 shares outstanding.
              What happened to Ocular Therapeutix’s price movement after its last earnings report?
              Ocular Therapeutix reported an EPS of -$0.39 in its last earnings report, missing expectations of -$0.263. Following the earnings report the stock price went up 2.344%.
                Which hedge fund is a major shareholder of Ocular Therapeutix?
                Among the largest hedge funds holding Ocular Therapeutix’s share is Graham Capital Management, L.P.. It holds Ocular Therapeutix’s shares valued at 409K.


                  Ocular Therapeutix Stock Smart Score

                  The Ocular Therapeutix stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Ocular Therapeutix

                  Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.


                  Top 5 ETFs holding OCUL

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  iShares Russell 3000 ETF
                  Dimensional U.S. Equity ETF
                  Invesco Nasdaq Biotechnology ETF
                  Up to five ETFs with an Outperform Smart Score that hold OCUL. The ETFs are listed according to market value of OCUL within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Ovid Therapeutics
                  Aptose Biosciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis